We also showed aggravated hepatic steatosis, inflammation, fibrosis and metabolic deterioration in Gdf15-knockout (Gdf15−/−) mice fed two different NASH diets, while these pathologic and metabolic features were attenuated in GDF15-transgenic (GDF15-Tg) mice. This evidence concerns the gene GDF15 and fatty liver disease.